financetom
UG
financetom
/
Consumer Staples
/
UG
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
United-Guardian, Inc.UG
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products.

The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.

Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser.

The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

Latest News >
Veralto Q3 Adjusted EPS, Revenue Rise; 2025 Outlook Raised
Veralto Q3 Adjusted EPS, Revenue Rise; 2025 Outlook Raised
Oct 28, 2025
04:57 PM EDT, 10/28/2025 (MT Newswires) -- Veralto ( VLTO ) reported Q3 adjusted earnings late Tuesday of $0.99 per diluted share, up from $0.89 a year earlier. Analysts polled by FactSet expected $0.95. Sales for the quarter ended Oct. 3 were $1.40 billion, up from $1.31 billion a year earlier. Analysts surveyed by FactSet expected $1.40 billion. The company...
Range Resources Q3 Adjusted Earnings, Revenue Rise
Range Resources Q3 Adjusted Earnings, Revenue Rise
Oct 28, 2025
04:55 PM EDT, 10/28/2025 (MT Newswires) -- Range Resources ( RRC ) reported Q3 adjusted earnings late Tuesday of $0.57 per diluted share, up from $0.48 a year earlier. Analysts polled by FactSet expected $0.53. Total revenue and other income for the quarter ended Sept. 30 was $748.5 million, up from $615.1 million a year earlier. Analysts surveyed by FactSet...
Insight Digital Partners II Announces Pricing of $150 Million Initial Public Offering
Insight Digital Partners II Announces Pricing of $150 Million Initial Public Offering
Oct 28, 2025
NEW YORK, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Insight Digital Partners II (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market (“Nasdaq”) and are expected to trade under the ticker symbol “DYORU” beginning on October 29, 2025....
Modine Fiscal Q2 Adjusted Earnings, Revenue Rise
Modine Fiscal Q2 Adjusted Earnings, Revenue Rise
Oct 28, 2025
04:56 PM EDT, 10/28/2025 (MT Newswires) -- Modine Manufacturing ( MOD ) reported fiscal Q2 adjusted earnings late Tuesday of $1.06 per share, up from $0.97 a year earlier. Analysts polled by FactSet expected $1.01. Revenue for the three months ended Sept. 30 was $738.9 million, up from $658.0 million a year earlier. Analysts surveyed by FactSet expected $698.4 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved